These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 15895792)

  • 1. [Epidemiology and prevention of cardiovascular diseases].
    Jánosi A
    Orv Hetil; 2005 Apr; 146(15):683-8. PubMed ID: 15895792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacologic prevention of cardiovascular diseases--2005].
    Kancz S
    Orv Hetil; 2005 May; 146(20 Suppl 2):1122-31. PubMed ID: 15945241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [20 years of cardiovascular epidemiology. The epidemiologist's viewpoint].
    Kornitzer M
    Rev Epidemiol Sante Publique; 1996 Nov; 44(6):563-76. PubMed ID: 9005492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary prevention of cardiovascular disease].
    Katić T; Sakić I; Bergovec M
    Acta Med Croatica; 2009 Feb; 63(1):71-4. PubMed ID: 19681467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular risk factors. Insights from Framingham Heart Study].
    O'Donnell CJ; Elosua R
    Rev Esp Cardiol; 2008 Mar; 61(3):299-310. PubMed ID: 18361904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Cardiovascular diseases.
    Nishtar S; Faruqui AM; Mattu MA; Mohamud KB; Ahmed A
    J Pak Med Assoc; 2004 Dec; 54(12 Suppl 3):S14-25. PubMed ID: 15745323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery disease prevention: what's different for women?
    Bedinghaus J; Leshan L; Diehr S
    Am Fam Physician; 2001 Apr; 63(7):1393-400, 1405-6. PubMed ID: 11310652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.
    Greving JP; Buskens E; Koffijberg H; Algra A
    Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug treatment and cost of cardiovascular disease in Australia.
    Ademi Z; Liew D; Chew D; Conner G; Shiel L; Nelson M; Soman A; Steg G; Bhatt DL; Reid C;
    Cardiovasc Ther; 2009; 27(3):164-72. PubMed ID: 19689615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary and secondary prevention of the acute coronary syndrome].
    Weingärtner O; Laufs U
    Hamostaseologie; 2006 May; 26(2):158-66; quiz 167-8. PubMed ID: 16676060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular diseases secondary to active and passive smoking].
    Goich J
    Rev Med Chil; 1995 May; 122(5):556-62. PubMed ID: 7724898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular diseases, medical apocalypse of the 21st century?].
    Mielnik M; Steciwko A
    Przegl Lek; 2004; 61(3):159-64. PubMed ID: 15518325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing pattern of cardiovascular diseases in China.
    Yao C; Wu Z; Wu Y
    World Health Stat Q; 1993; 46(2):113-8. PubMed ID: 8303905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of cardiovascular disease--opportunities for progress.
    Oberman A; Kuller LH; Carleton RA
    Prev Med; 1994 Sep; 23(5):727-32. PubMed ID: 7845948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution of cardiovascular risk factors in coronary patients in Sahel, Tunisia].
    Lihioui M; Boughzala E; Ben Farhat M; Ammar H; Chaouech A; Jemaa R; Kaabachi N
    East Mediterr Health J; 2007; 13(3):536-43. PubMed ID: 17687825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risk patient--how much prevention is necessary and rational?].
    Seiler C
    Praxis (Bern 1994); 1998 Jan; 87(5):135-40, 142, 144. PubMed ID: 9522631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.